Kentron Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-06-2024
- Paid Up Capital ₹ 1.00 M
as on 25-06-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Revenue -34.30%
(FY 2019)
- Profit -68.44%
(FY 2019)
- Ebitda -30.20%
(FY 2019)
- Net Worth 12.51%
(FY 2019)
- Total Assets -7.13%
(FY 2019)
About Kentron Biotechnology
The Corporate was formerly known as Kentron Clinisearch Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Bidargaddi Varada and Shailendra Shettennavar serve as directors at the Company.
- CIN/LLPIN
U24230KA2009PTC049127
- Company No.
049127
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2009
- Date of AGM
23 Aug 2021
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kentron Biotechnology Private Limited offer?
Kentron Biotechnology Private Limited offers a wide range of products and services, including Corporate and Soft Skills Training, Corporate Training.
Who are the key members and board of directors at Kentron Biotechnology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bidargaddi Varada  | Director | 12-Feb-2009 | Current |
| Shailendra Shettennavar | Director | 12-Feb-2009 | Current |
Financial Performance of Kentron Biotechnology.
Kentron Biotechnology Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 34.3% decrease. The company also saw a substantial fall in profitability, with a 68.44% decrease in profit. The company's net worth Soared by an impressive increase of 12.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kentron Biotechnology?
In 2019, Kentron Biotechnology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kaairosh Innovation (Opc) Private LimitedActive 5 years 6 months
Bidargaddi Varada is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kentron Biotechnology?
Unlock and access historical data on people associated with Kentron Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kentron Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kentron Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
